相关实验视频

Updated: Jun 16, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

胎儿NT-proBNP度对母亲贫血的反应:对满期怀孕的研究

Kadriye Erdogan¹, Izzet Ozgurluk¹, Dilara Kurt¹

¹Department of Gynecology and Obstetrics, Ankara Etlik City Hospital, Ankara, Turkey.

Fetal and pediatric pathology

|June 14, 2025

概括

胎儿N-终端B型亲尿素 (NT-proBNP) 水平在贫血怀孕的带血液中较高. 这表明NT-proBNP可能表明胎儿心血管适应在孕产妇贫血中缺氧.

科学领域:

产科和妇科产科和妇科
新生儿研究新生儿研究
心血管生理学心血管生理学

背景情况:

孕产妇贫血是怀孕期间常见的并发症.
胎儿缺氧可能是严重的母体贫血的结果.
暴露于贫血的胎儿的心血管适应需要进一步调查.

研究的目的:

为了评估胎儿在带血中的N-终端亲B型尿素度 (NT-proBNP).
为了比较具有和没有母体贫血的满期怀孕之间的NT-proBNP水平.
探索母亲贫血标志物与胎儿NT-proBNP之间的关系.

主要方法:

一项前性病例控制研究,涉及90名孕妇 (45名贫血,45名非贫血).
在带血中分析NT-proBNP度.
收集母亲的血红蛋白和费里丁水平.

主要成果:

在母亲贫血组 (844.42 ± 746.9 pg/mL) 与非贫血组 (510.87 ± 378.52 pg/mL; p=0.01) 相比,在母亲贫血组观察到显著更高的NT-proBNP度.
在贫血组中,母亲的费里丁水平明显较低 (10.02 ± 6.81 vs 37.02 ± 9.79; p<0.001).
在母体血红蛋白水平和胎儿NT-proBNP度之间发现了显著的反向关系 (β = -76.27; p<0.001).

结论:

在贫血妊娠中胎儿NT-proBNP升高表明胎儿缺氧的补偿反应.
在母体贫血的背景下,NT-proBNP可以作为评估胎儿心血管适应的潜在生物标志物.
这些发现强调了监测胎儿健康在因贫血而复杂的怀孕中的重要性.

关键词:

胎儿心血管适应胎儿心血管适应在胎儿NT-proBNP中.孕产妇的贫血症产妇的贫血症带血是指带血的血液.

更多相关视频

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo

High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo

Published on: November 8, 2018

相关概念视频

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...